Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andreia Da Silva de Oliveira"'
Autor:
Natan de Azevedo Padilha, Tatielle dos Santos Brigido, Camila de Freitas Cardozo, Luciene Freitas Fernandes, Andreia da Silva de Oliveira, Julio Cesar Pinho Mattos
Publikováno v:
Scientia Naturalis. 3
Autor:
Natan de Azevedo Padilha, Tatielle dos Santos Brigido, Camila de Freitas Cardozo, Luciene Freitas Fernandes, Andreia da Silva de Oliveira, Julio Cesar Pinho Mattos, Nathocley Mendes Venâncio
Publikováno v:
Scientia Naturalis. 3
Autor:
Andreia Da Silva de Oliveira, Robson Q. Monteiro, Vitor H. Almeida, Alireza R. Rezaie, Fausto G. Gomes
Publikováno v:
Biochemical and biophysical research communications. 495(1)
Activated Protein C (APC) is a serine-protease that displays antithrombotic and anti-inflammatory properties. In addition, cleavage of protease-activated receptor 1 (PAR1) by APC exerts endothelial cytoprotective actions. The effects of APC on endoth
Autor:
Juliana Echevarria-Lima, Andreia Da Silva de Oliveira, Likiu Yang, Alireza R. Rezaie, Robson Q. Monteiro
Publikováno v:
Melanoma Research. 24:11-19
Malignant melanoma cells are known to have altered expressions of growth factors as compared with normal melanocytes. Thrombomodulin (TM) is a thrombin receptor on endothelial cells that converts thrombin from a procoagulant to an anticoagulant enzym
Autor:
Andréa Mariano-Oliveira, Luize G. Lima, Ivo M.B. Francischetti, Luiz Eurico Nasciutti, Andreia Da Silva de Oliveira, John F. Andersen, Robson Q. Monteiro, Daniel Escorsim Machado, Lars Christian Petersen
Publikováno v:
Thrombosis Research. 130:e163-e170
Melanoma is a highly metastatic cancer and there is strong evidence that the clotting initiator protein, tissue factor (TF), contributes to its aggressive pattern. TF inhibitors may attenuate primary tumor growth and metastasis. In this study, we eva
Autor:
Elaine Gray, Clarice Kirszberg, Andreia Da Silva de Oliveira, Robson Q. Monteiro, Luize G. Lima, William M. Pickering, Trevor W. Barrowcliffe, Vivian M. Rumjanek
Publikováno v:
Melanoma Research. 19:301-308
A correlation between cancer and hypercoagulability has been described for more than a century. Patients with cancer are at increased risk for thrombotic complications, and the clotting initiator protein, tissue factor (TF), is possibly involved in t
Autor:
Martin Bonamino, Andreia Da Silva de Oliveira, Robson Q. Monteiro, Lars Christian Petersen, Cristina P. Vicente, Claudio C. Werneck, Roger Chammas, Luiza C. Campos, Marcello A. Barcinski, Luize G. Lima
Publikováno v:
Thrombosis and haemostasis. 106(4)
SummaryShedding of microvesicles (MVs) by cancer cells is implicated in a variety of biological effects, including the establishment of cancer-associated hypercoagulable states. However, the mechanisms underlying malignant transformation and the acqu
Autor:
Nivea Dias Amoedo, Franklin David Rumjanek, Ottilia R. Affonso-Mitidieri, Vivian M. Rumjanek, Sandra Rodrigues-Mascarenhas, Andreia Da Silva de Oliveira
Publikováno v:
Annals of the New York Academy of Sciences. 1153
Ouabain, a known inhibitor of the Na,K-ATPase, has been shown to regulate a number of lymphocyte functions in vitro and in vivo. Lymphocyte proliferation, apoptosis, cytokine production, and monocyte function are all affected by ouabain. The ouabain-